GLP-1 meds—perhaps better known by brand names like Ozempic and Wegovy—have become widespread as weight loss tools. But there's evidence that links their use to to a range of positive health outcomes, and now researchers say they may "alter social and economic outcomes" too.
Specifically, relationship outcomes. In a new National Bureau of Economic Research working paper, the Harvard economist Rebecca Diamond found GLP-1 use linked to higher likelihood of marriage or cohabitation.
